A. A. Artenie

发表

Sexual behaviour as a risk factor for hepatitis C virus infection among people who inject drugs in Montreal, Canada

Nanor Minoyan, J. Bruneau, É. Roy, 2019, Journal of viral hepatitis.

Homelessness, unstable housing, and risk of HIV and hepatitis C virus acquisition among people who inject drugs: a systematic review and meta-analysis

Josephine G. Walker, M. Hellard, A. Trickey, 2021, The Lancet. Public health.

High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.

E. Fortier, J. Bruneau, É. Roy, 2017, The International journal on drug policy.

Impact of hepatitis C virus point-of-care RNA viral load testing compared with laboratory-based testing on uptake of RNA testing and treatment, and turnaround times: a systematic review and meta-analysis.

Philippa J Easterbrook, A. Trickey, E. Fajardo, 2023, The lancet. Gastroenterology & hepatology.

Associations between housing stability and injecting frequency fluctuations: findings from a cohort of people who inject drugs in Montréal, Canada.

Nanor Minoyan, M. Sylvestre, E. Fortier, 2019, Drug and alcohol dependence.

The role of prevention strategies in achieving HCV elimination in Canada: what are the remaining challenges?

Nanor Minoyan, J. Bruneau, J. Grebely, 2018, Canadian liver journal.

Progress and remaining challenges to address hepatitis C, other infectious diseases, and drug-related harms to improve the health of people who use drugs.

J. Lazarus, C. Treloar, J. Grebely, 2021, The International journal on drug policy.

Conceptualising access in the direct-acting antiviral era: An integrated framework to inform research and practice in HCV care for people who inject drugs.

Nanor Minoyan, J. Bruneau, B. Jacka, 2019, The International journal on drug policy.

Portraying Persons Who Inject Drugs Recently Infected with Hepatitis C Accessing Antiviral Treatment: A Cluster Analysis

Jean-Marie Bamvita, J. Bruneau, É. Roy, 2014, Hepatitis research and treatment.

Associations of substance use patterns with attempted suicide among persons who inject drugs: can distinct use patterns play a role?

F. Lespérance, J. Tremblay, J. Bruneau, 2015, Drug and alcohol dependence.

Patterns of drug, alcohol use and injection equipment sharing among people with recent injecting drug use or receiving opioid agonist treatment during and following hepatitis C virus treatment with direct-acting antiviral therapies: An international study.

C. Stedman, B. Conway, M. Hellard, 2020, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

Injecting frequency trajectories and hepatitis C virus acquisition: Findings from a cohort of people who inject drugs in Montréal, Canada.

Nanor Minoyan, M. Sylvestre, E. Fortier, 2021, The International journal on drug policy.

Short-term injection drug use changes following hepatitis C virus (HCV) assessment and treatment among persons who inject drugs with acute HCV infection.

M. Daniel, E. Fortier, J. Bruneau, 2017, The International journal on drug policy.

Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infection.

J. Stone, P. Vickerman, M. Hickman, 2021, The International journal on drug policy.

Visits to primary care physicians among persons who inject drugs at high risk of hepatitis C virus infection: room for improvement

Jean-Marie Bamvita, J. Bruneau, É. Roy, 2015, Journal of viral hepatitis.

Socioeconomic stability is associated with lower injection frequency among people with distinct trajectories of injection drug use.

Nanor Minoyan, L. Gauvin, M. Sylvestre, 2021, The International journal on drug policy.

Opioid agonist treatment dosage and patient-perceived dosage adequacy, and risk of hepatitis C infection among people who inject drugs

Nanor Minoyan, L. Gauvin, J. Bruneau, 2019, Canadian Medical Association Journal.

Examining the link between psychological distress, mental health disorders and sharing behaviors among cocaine users.

J. Bruneau, É. Roy, D. Jutras-Aswad, 2016, Addictive behaviors.

Harm Reduction Coverage and Hepatitis C Incidence: Findings From a Cohort of People Who Inject Drugs.

Nanor Minoyan, Marie-Ève Turcotte, J. Bruneau, 2020, American journal of preventive medicine.

The authors respond to “Opioid agonist dosage adequacy from clinical and patient perspectives: further considerations”

J. Bruneau, A. A. Artenie, 2019, Canadian Medical Association Journal.

Licit and illicit substance use among people who inject drugs and the association with subsequent suicidal attempt.

F. Lespérance, J. Tremblay, J. Bruneau, 2015, Addiction.

Striving toward hepatitis C elimination in the era of COVID-19.

Nanor Minoyan, M. Palmer, Ching-Hsuan Liu, 2021, Canadian liver journal.

Short and sporadic injecting cessation episodes as predictors of incident hepatitis C virus infection: findings from a cohort study of people who inject drugs in Montréal, Canada.

E. Fortier, J. Bruneau, J. Grebely, 2019, Addiction.

Hepatitis C Virus seroconversion among persons who inject drugs in relation to primary care physician visiting: The potential role of primary healthcare in a combined approach to Hepatitis C prevention.

Jean-Marie Bamvita, M. Daniel, J. Bruneau, 2015, The International journal on drug policy.

Neurostimulation for Refractory Cervicogenic Headache: A Three‐Year Retrospective Study

P. Lespérance, E. Leroux, L. Beaudet, 2018, Neuromodulation : journal of the International Neuromodulation Society.

Role of primary care providers in hepatitis C prevention and care: one step away from evidence-based practice.

J. Bruneau, A. Artenie, A. Lévesque, 2014, Canadian family physician Medecin de famille canadien.

High hepatitis C incidence in relation to prescription opioid injection and poly-drug use: Assessing barriers to hepatitis C prevention.

E. Fortier, J. Bruneau, É. Roy, 2017, The International journal on drug policy.